+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Adenosine"

Barth Syndrome - Pipeline Insight, 2021 - Product Thumbnail Image

Barth Syndrome - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
Adenosine Receptor A3 - Pipeline Review, H2 2020 - Product Thumbnail Image

Adenosine Receptor A3 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 89 Pages
  • Global
From
From
From
From
From
From
From
Adenosine (CAS 58-61-7) Global Market Research Report 2024 - Product Thumbnail Image

Adenosine (CAS 58-61-7) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
From
From
From
Loading Indicator

Adenosine is a drug used in the treatment of endocrine and metabolic disorders. It is a purine nucleoside that acts as a neuromodulator, regulating the activity of various neurotransmitters and hormones. Adenosine is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to treat certain types of heart failure, as well as to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms. Adenosine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms, and is often prescribed in combination with other drugs. Some companies in the Adenosine market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more